NSAIDs Are Safe in Angle-Closure Glaucoma
NSAIDs do not trigger or worsen angle-closure glaucoma and can be used safely in these patients. The medications that precipitate acute angle-closure glaucoma are primarily anticholinergics, adrenergic agonists (decongestants), sulfonamides, and serotonergic agents—NSAIDs are not among the culprit drug classes 1, 2, 3.
Why NSAIDs Are Not Implicated
The pathophysiology of drug-induced acute angle-closure glaucoma involves two main mechanisms 1:
- Pupillary block with mydriasis - caused by anticholinergics (atropine, antidepressants), adrenergic agents (phenylephrine, ephedrine), and cholinergics (pilocarpine paradoxically)
- Anterior displacement of lens-iris diaphragm - caused by sulfonamides (topiramate, acetazolamide, hydrochlorothiazide) through ciliary body edema
NSAIDs work through cyclooxygenase inhibition and prostaglandin reduction 4. They have no anticholinergic, adrenergic, or sulfonamide properties that would trigger angle closure.
Topical Ophthalmic NSAIDs: A Different Safety Profile
The evidence regarding topical ophthalmic NSAIDs addresses corneal complications, not glaucoma 4, 5, 6. These agents are commonly used after cataract surgery and for ocular inflammation without any documented effect on intraocular pressure or angle-closure risk 4. The main concerns with topical NSAIDs are:
- Corneal ulceration and melts (particularly with generic diclofenac)
- Local irritation and burning
- Risk increased when combined with corticosteroids in inflamed corneas
Notably, topical NSAIDs have an "unknown effect on ocular pressure" per the literature 4, meaning they neither raise IOP nor trigger angle closure.
Systemic NSAIDs: No Glaucoma Risk
The comprehensive reviews of drug-induced acute angle-closure glaucoma 1, 2, 3, 7 consistently identify the same culprit medications—and NSAIDs are conspicuously absent from these lists. The most recent 2026 systematic reviews 3, 7 specifically enumerate:
- Sulfonamides (topiramate most common)
- Anticholinergics (tricyclic antidepressants, antihistamines)
- Adrenergic agents (decongestants like phenylephrine)
- Serotonergic agents (SSRIs, triptans)
- Cholinergics (pilocarpine)
Clinical Bottom Line
You can prescribe both systemic and topical NSAIDs to patients with angle-closure glaucoma without concern for precipitating an acute attack or worsening their condition. The angle-closure disease guidelines 8 focus management on laser iridotomy, aqueous suppressants, and parasympathomimetics for acute attacks—with no mention of avoiding NSAIDs.
Important Caveat for Topical Ophthalmic NSAIDs
If prescribing topical ophthalmic NSAIDs post-operatively, avoid concurrent use with topical corticosteroids in patients with significant pre-existing corneal inflammation or epithelial defects, as this combination increases risk of corneal melts 5. This is a corneal safety issue, not a glaucoma concern.